Treatment of melanoma with alpha thymosin peptides in combination with a kinase inhibitor

Details for Australian Patent Application No. 2008335025 (hide)

Owner SciClone Pharmaceuticals, Inc.

Inventors Rios, Israel; Tuthill, Cynthia W.

Agent Wrays

Pub. Number AU-A-2008335025

PCT Pub. Number WO2009/076587

Priority 61/013,476 13.12.07 US

Filing date 12 December 2008

Wipo publication date 18 June 2009

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/24 (2006.01) Medicinal preparations containing peptides - Follicle-stimulating hormone (FSH)

Event Publications

24 June 2010 PCT application entered the National Phase

  PCT publication WO2009/076587 Priority application(s): WO2009/076587

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008335029-Antiperspirant active compositions having SEC chromatogram exhibiting high SEC Peak 4 intensity

2008335013-System and method for regenerating an absorbent solution